Fig. 4: PROM2 enhances gemcitabine chemoresistance in pancreatic cancer in vivo. | Experimental & Molecular Medicine

Fig. 4: PROM2 enhances gemcitabine chemoresistance in pancreatic cancer in vivo.

From: PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer

Fig. 4

a Luminescence signal of xenografted tumors formed by indicated cells in mice after gemcitabine treatment. b The changes of tumor volume and luminescence with gemcitabine treatment in indicated cells (mean value is plotted). c Representative images of tumor mass removed from mice with xenografted tumors. d Tumor weight (mg) of the collected tumor mass removed from mice xenografted with indicated cancer cells (*P < 0.05). e Representative images of PROM2 and TUNEL immunostaining in indicated tumor tissues; the quantification of results is shown on the right panel (*P < 0.05), the PROM2 expression of vector group has been set as 1.

Back to article page